MAP2K2 and cardiofaciocutaneous syndrome: Mutations downstream of Raf in the Ras/Raf/MEK/ERK cascade have not been frequently detected in human cancer although there are some rare germline mutations detected at MEK1 and MEK2 in cardiofaciocutaneous syndrome (CFC) [82].